Annexin Pharmaceuticals AB (publ)
ANNX SE0009664154
ICB 2010 : Health Care / Health CareSweden 111 60
SE-AB Stockholm KAMMAKARGATAN 48
Registration Number 556960-9539
Founded 2014
Previous Name(s):
Annexin Pharmaceuticals AB
Visionsbolaget 8424 AB
Annual Performance 1
2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
2090% | 553% | 409% | 359% | 72% |
Historical Performance 1
1M | 3M | 6M | 1Y | 3Y | 5Y | All Time |
---|---|---|---|---|---|---|
-4% | -20% | -93% | 87% | -92% | -98% | -93% |
Annual Insiders Turnover, USD 2
2019 | 2020 | 2022 | 2024 |
---|---|---|---|
6,497.45 | 17,214.73 | 9,073.89 | 16,653.99 |
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 10 Insiders: 5
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Mikael Lönn DIR |
0.25 SEK |
560,000 Bought |
140,000 SEK |
03/07/2024 | 03/07/2024 |
Nils Anders Haegerstrand CEO |
0.25 SEK |
145,600 Bought |
36,400 SEK |
03/07/2024 | 03/07/2024 |
Uli Hacksell CB |
0.87 SEK |
100,000 Bought |
86,900 SEK |
17/03/2022 | 15/03/2022 |
Carl-fredrik Lindner CB |
1.80 SEK |
40,688 Bought |
73,238 SEK |
24/12/2020 | 23/12/2020 |
Carl-fredrik Lindner CB |
1.77 SEK |
2,000 Bought |
3,540 SEK |
24/12/2020 | 23/12/2020 |
Carl-fredrik Lindner CB |
1.78 SEK |
3,000 Bought |
5,340 SEK |
24/12/2020 | 23/12/2020 |
Carl-fredrik Lindner CB |
1.78 SEK |
29,998 Bought |
53,396 SEK |
24/12/2020 | 23/12/2020 |
Carl-fredrik Lindner CB |
1.80 SEK |
2,145 Bought |
3,850 SEK |
24/12/2020 | 23/12/2020 |
Carl-fredrik Lindner CB |
1.78 SEK |
2,169 Bought |
3,850 SEK |
24/12/2020 | 23/12/2020 |
Jamal El Mosleh CEO |
1.59 SEK |
38,452 Bought |
61,139 SEK |
11/03/2019 | 11/03/2019 |